Brief: Olink Establishes Agreement With Regeneron Genetics Center To Scale Their Proteomics Efforts, Potentially Enabling A New Era Of Drug Discovery

Olink Holding AB (publ)

28/02/2023 14:51

Olink Holding AB (publ)  OLK.O :
    * OLINK ESTABLISHES AGREEMENT WITH REGENERON GENETICS CENTER
TO
SCALE THEIR PROTEOMICS EFFORTS, POTENTIALLY ENABLING A NEW ERA
OF DRUG DISCOVERY

Source text for Eikon:  ID:nGNX17jmKG 
Further company coverage:  OLK.O